Sorrento Therapeutics, Inc. Business Finance Contracts & Agreements

133 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Asset Purchase Agreement between Sorrento Therapeutics, Inc. and Yuhan Corporation dated October 30, 2023
Purchase Agreements
Sorrento Therapeutics, Inc.
Biotechnology
DE
2023
Stock Purchase Agreement between Sorrento Therapeutics, Inc. and Dr. Robert J. Hariri, M.D., Ph.D. dated September 29, 2023
Stock Agreements
Sorrento Therapeutics, Inc.
Biotechnology
TX
2023
Assignment, Assumption and Release Agreement among Scilex Holding Company, Oramed Pharmaceuticals Inc., Sorrento Therapeutics, Inc., and Scintilla Pharmaceuticals, Inc.
Assignment Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2023
Mutual Termination and Release Agreement between Sorrento Therapeutics, Inc. and Oramed Pharmaceuticals, Inc.
Release Agreements
Sorrento Therapeutics, Inc.
Biotechnology
TX
2023
Stock Purchase Agreement between Scilex Holding Company and Sorrento Therapeutics, Inc. dated September 21, 2023
Purchase Agreements
Sorrento Therapeutics, Inc.
Biotechnology
TX
2023
Second Amendment to Stock Purchase Agreement between Sorrento Therapeutics, Inc. and Oramed Pharmaceuticals Inc.
Purchase Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2023
Senior Secured, Super-Priority Debtor-in-Possession Loan and Security Agreement among Sorrento Therapeutics, Scintilla Pharmaceuticals, and Oramed Pharmaceuticals (August 9, 2023)
Loan Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2023
First Amendment to Stock Purchase Agreement between Sorrento Therapeutics, Inc. and Oramed Pharmaceuticals Inc.
Purchase Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2023
Stock Purchase Agreement between Oramed Pharmaceuticals Inc. and Sorrento Therapeutics, Inc. (August 7, 2023)
Purchase Agreements
Sorrento Therapeutics, Inc.
Biotechnology
TX
2023
Intercreditor and Subordination Agreement among JMB Capital Partners Lending, LLC and Scilex Holding Company, dated July 5, 2023
Subordination Agreement
Sorrento Therapeutics, Inc.
Biotechnology
NY
2023
Debtor-in-Possession Term Loan Facility Agreement between Sorrento Therapeutics, Inc., Scintilla Pharmaceuticals, Inc., and Scilex Holding Company
Credit Agreements
Sorrento Therapeutics, Inc.
Biotechnology
TX
2023
Senior Secured, Super-Priority Debtor-in-Possession Loan and Security Agreement by and among Sorrento Therapeutics, Inc., Scintilla Pharmaceuticals, Inc., and JMB Capital Partners...
Loan Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2023
Bridge Loan Agreement between Sorrento Therapeutics, Inc. and B. Riley Commercial Capital, LLC (September 30, 2022)
Loan Agreements
Sorrento Therapeutics, Inc.
Biotechnology
DE
2022
Amendment No. 1 to Sponsor Support Agreement among Vickers Venture Fund VI Entities, Vickers Vantage Corp I, and Scilex Holding Company
Modification Agreements
Sorrento Therapeutics, Inc.
Biotechnology
2022
Stockholder Agreement between Vickers Vantage Corp. I and Sorrento Therapeutics, Inc. (September 12, 2022)
Shareholders Agreements
Sorrento Therapeutics, Inc.
Biotechnology
DE
2022
Contribution and Satisfaction of Indebtedness Agreement among Sorrento Therapeutics, Scilex Holding Company, and Scilex Pharmaceuticals (September 12, 2022)
Contribution Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2022
Consent and Amendment No. 4 to Indenture among Scilex Pharmaceuticals, Sorrento Therapeutics, and U.S. Bank Trust Company
Indenture Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2022
Amended and Restated Registration Rights Agreement among Scilex Holding Company, Sponsor Equityholders, and Sorrento Therapeutics, Inc.
Registration Rights Agreements
Sorrento Therapeutics, Inc.
Biotechnology
DE
2022
Description of Securities Registered under Section 12 of the Exchange Act by Sorrento Therapeutics, Inc.
Stock Agreements
Sorrento Therapeutics, Inc.
Biotechnology
2022
Amendment No. 1 to Amended and Restated Sales Agreement between Sorrento Therapeutics, Inc. and Sales Agents
Modification Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2021
Amended and Restated Common Stock Sales Agreement between Sorrento Therapeutics, Inc. and Sales Agents (Cantor Fitzgerald & Co., B. Riley Securities, Inc., H.C. Wainwright & Co.,...
Equity Distribution Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2021
Loan Agreement between Zhejiang ACEA Pharmaceutical Co., Ltd. and ACEA Bio (Hangzhou) Co., Ltd.
Loan Agreements
Sorrento Therapeutics, Inc.
Biotechnology
2021
Loan Agreement between Hangzhou ACEA Pharmaceutical Research Co., Ltd. and ACEA Bio (Hangzhou) Co., Ltd. dated August 15, 2018
Loan Agreements
Sorrento Therapeutics, Inc.
Biotechnology
2021
Amendment to Term Sheet Between Sorrento Therapeutics, Inc. and ANP Technologies, Inc. Extending Standstill Period
Modification Agreements
Sorrento Therapeutics, Inc.
Biotechnology
2021
Term Sheet for Acquisition of ANP Technologies, Inc. by Sorrento Therapeutics, Inc.
Term Sheets
Sorrento Therapeutics, Inc.
Biotechnology
CA
2021
Description of Securities Registered Under Section 12 of the Exchange Act by Sorrento Therapeutics, Inc.
Equity Distribution Agreements
Sorrento Therapeutics, Inc.
Biotechnology
2021
Consent and Amendment No. 3 to Indenture and Letter of Credit among Scilex Pharmaceuticals, Sorrento Therapeutics, U.S. Bank, and Noteholders
Indenture Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2020
Amendment No. 1 to Sales Agreement between Sorrento Therapeutics, Inc. and A.G.P./Alliance Global Partners
Modification Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2020
Sorrento Therapeutics, Inc. Performance Stock Option Award Agreement with Henry Ji, Ph.D.
Stock Agreements
Sorrento Therapeutics, Inc.
Biotechnology
CA
2020
Sorrento Therapeutics, Inc. 2020 Employee Stock Purchase Plan
Equity Distribution Agreements
Sorrento Therapeutics, Inc.
Biotechnology
DE
2020
First Amendment to Exchange and Registration Rights Agreement between Sorrento Therapeutics, Inc. and Fortis Advisors LLC
Modification Agreements
Sorrento Therapeutics, Inc.
Biotechnology
DE
2020
Binding Letter of Intent for Acquisition of Levena (Suzhou) Biopharma Co., Ltd. by Nanjing Hongjing Enterprise Management Consulting Co., Ltd.
Term Sheets
Sorrento Therapeutics, Inc.
Biotechnology
DE
2020
Omnibus Amendment No. 2 to Indenture and Letter of Credit among Scilex Pharmaceuticals Inc., Sorrento Therapeutics, Inc., U.S. Bank National Association, and Noteholders
Indenture Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2020
Common Stock Purchase Agreement between Sorrento Therapeutics, Inc. and Arnaki Ltd. dated April 27, 2020
Purchase Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2020
Common Stock Sales Agreement between Sorrento Therapeutics, Inc. and A.G.P./Alliance Global Partners (April 27, 2020)
Equity Distribution Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2020
Description of Securities Registered under Section 12 of the Exchange Act – Sorrento Therapeutics, Inc.
Stock Agreements
Sorrento Therapeutics, Inc.
Biotechnology
2020
Common Stock Purchase Agreement between Sorrento Therapeutics, Inc. and Aspire Capital Fund, LLC (February 10, 2020)
Purchase Agreements
Sorrento Therapeutics, Inc.
Biotechnology
IL
2020
Registration Rights Agreement between Sorrento Therapeutics, Inc. and Aspire Capital Fund, LLC (February 10, 2020)
Registration Rights Agreements
Sorrento Therapeutics, Inc.
Biotechnology
IL
2020
Amendment No. 2 to Registration Rights Agreement by and among Sorrento Therapeutics, Inc. and Holders
Registration Rights Agreements
Sorrento Therapeutics, Inc.
Biotechnology
DE
2019
Common Stock Purchase Warrant Agreement between Sorrento Therapeutics, Inc. and Investor
Warrant Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2019